[QODLink]
The Cure

Unsung Hero: Louise Pearce

How the physician risked her life to test a new drug she believed would cure sleeping sickness.

Last updated: 21 Jan 2014 11:21
Email Article
Print Article
Share article
Send Feedback

Louise Pearce risked her life to test a new drug she believed would cure sleeping sickness.

In 1920, a sleeping sickness epidemic broke out across some African countries, with the Congo - at that time a Belgian colony - one of the worst hit.

Dr Louise Pearce volunteered to travel alone to the colony to test out a drug she believed could help cure victims. For decades, the drug, Tryparsamide remained the standard treatment for sleeping sickness.

Following her success, Louise Pearce returned to the US and continued her research into susceptibility and resistance to infection with Dr Wade Hampton Brown. She retired in 1951 and died eight years later following a short illness.

 

 

Click here for more on The Cure 

 

170

Source:
Al Jazeera
Email Article
Print Article
Share article
Send Feedback
Topics in this article
People
Country
Featured on Al Jazeera
'Justice for All' demonstrations swell across the US over the deaths of African Americans in police encounters.
Six former Guantanamo detainees are now free in Uruguay with some hailing the decision to grant them asylum.
Disproportionately high number of Aboriginal people in prison highlights inequality and marginalisation, critics say.
Nearly half of Canadians have suffered inappropriate advances on the job - and the political arena is no exception.
Featured
Women's rights activists are demanding change after Hanna Lalango, 16, was gang-raped on a bus and left for dead.
Buried in Sweden's northern forest, Sorsele has welcomed many unaccompanied kids who help stabilise a town exodus.
A look at the changing face of North Korea, three years after the death of 'Dear Leader'.
While some fear a Muslim backlash after café killings, solidarity instead appears to be the order of the day.
Victims spared by the deadly disease are reporting blindness and other unexpected post-Ebola health issues.
join our mailing list